Core Viewpoint - As of August 1, 2025, Kangtong Medical (301515) closed at 22.75 yuan, marking a 3.41% increase, with a trading volume of 37,000 hands and a turnover of 83.2752 million yuan [1] Financial Performance - The company reported a main revenue of 24.2867 million yuan for Q1 2025, a year-on-year decline of 68.09% - The net profit attributable to shareholders was 1.579 million yuan, down 85.25% year-on-year - The net profit after deducting non-recurring gains and losses was 1.4143 million yuan, a decrease of 86.46% year-on-year - The debt ratio stood at 36.26%, with financial expenses of -515,200 yuan and a gross profit margin of 36.15% [5] Market Activity - On August 1, 2025, the net inflow of main funds was 1.4782 million yuan, accounting for 1.78% of the total turnover - Retail investors experienced a net outflow of 2.1398 million yuan, representing 2.57% of the total turnover [1][2] - The financing balance on August 1, 2025, was 43.3562 million yuan, with a net repayment of financing amounting to 1.502 million yuan [3] Industry Comparison - Kangtong Medical's total market value is 2.275 billion yuan, compared to the industry average of 11.474 billion yuan, ranking 117th out of 122 in the medical device industry - The company's net assets are 1.248 billion yuan, significantly lower than the industry average of 3.918 billion yuan, ranking 97th out of 122 - The price-to-earnings ratio (P/E) is 360.21, compared to the industry average of 61.54, ranking 94th out of 122 [5]
港通医疗（301515）8月1日主力资金净买入147.82万元